Latest News
20-Feb-2025 Generic Pain, Margin Loss... Drug Cos may Find it Hard
19-Feb-2025 Pharma Market in Good Health; Lifestyle Diseases may be Rising
17-Feb-2025 Govt May Allow Slight Increase in Essential Drug Prices from Apr 1
14-Feb-2025 KKR Set to Acquire 51% in Cancer Chain HCG
13-Feb-2025 Pharma Cos Must File Compliance Strategy
  more...
Latest Reports
Jan-25 March of corporate hospitals: Deepening presence - Emkay Research  
Jan-25 US pricing pressure eases; margins improve - Nirmal Bang  
Jan-25 Chemicals/Pharma EXIM trends - Phillip Capital  
Jan-25 3QFY25 Preview: Change in script unlikely - Emkay Research  
Jan-25 Bed additions/ARPOB to drive growth during the quarter - Centrum Research  
  more...

Quarterly Summary September-2024
Desc Current Previous Per.Chg
Sales 67242.7 61013.1 10.2
Otherincome 2488.6 2287.7 8.8
Expense 49904.7 47193.7 5.7
RawMaterial 19003.4 18996.8 0.0
StaffCost 9916.5 9105.9 8.9
ExciseDuty 78.8 58.9 33.9
OtherExp 15371.3 14258.0 7.8
Interest 1058.2 1028.8 2.9
GrossProfit 20070.8 16023.1 25.3
Depreciation 2672.0 2717.1 -1.7
Tax 4076.5 2892.1 41.0
NetProfit 13339.3 10504.1 27.0
Total.Comp 176 -- --
Source: ETIG Database

Sectoral Companies As on 21 Feb 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 394216.99
Divi's Lab 152599.24
Cipla 119064.47
Torrent Phar 102741.92
Dr.Reddy's 96118.71
Mankind Phar 96003.77
Zydus Life 89058.76
Lupin 87015.75
Aurobindo Ph 65354.22
Abbott (I) 61506.43
Alkem Labora 55060.55
GlaxoSmith.P 42501.58
Glenmark Pha 36693.06
  click here for the complete list